18F-FDG PET: Parkinson’s disease (PD) versus controls, including regions of significant reduction in relative regional cerebral metabolic rate for glucose (rrCMRGlc)
| PD | Controls | Two tailed p | |
|---|---|---|---|
| Mean age (SD) | 61.3 (7.0) | 61.0 (5.5) | |
| Folstein Mini Mental State Examination (SD) | 29.9 (0.3) | 29.2 (1.3) | |
| FDG dose mCi (SD) | 4.89 (0.19) | 5.01 (0.41) | |
| Global CMRGlc (SD) (mg/100 ml/min) | 4.82 (0.37) | 4.77 (0.76) | 0.87 |
| Right parietal lobe rrCMRGlc (SD) | 0.977 (0.071) | 1.063 (0.031) | 0.001 |
| Right occipital lobe rrCMRGlc (SD) | 1.030 (0.096) | 1.110 (0.068) | 0.028 |